Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Fibroblast growth factor 23 and Inflammation in CKD.

Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M; Chronic Renal Insufficiency Cohort..

Clin J Am Soc Nephrol. 2012 Jul;7(7):1155-62. doi: 10.2215/CJN.13281211.

2.

Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.

Hanks LJ, Casazza K, Judd SE, Jenny NS, Gutiérrez OM.

PLoS One. 2015 Mar 26;10(3):e0122885. doi: 10.1371/journal.pone.0122885.

3.

Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.

Mehta R, Ying GS, Houston S, Isakova T, Nessel L, Ojo A, Go A, Lash J, Kusek J, Grunwald J, Wolf M; CRIC Study Investigators..

Nephrol Dial Transplant. 2015 Sep;30(9):1534-41. doi: 10.1093/ndt/gfv123.

4.

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.

Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M; CRIC Study Investigators..

Kidney Int. 2017 Mar;91(3):711-719. doi: 10.1016/j.kint.2016.10.021.

PMID:
28017325
6.

Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS; CRIC Study Investigators..

Clin J Am Soc Nephrol. 2012 Dec;7(12):1938-46. doi: 10.2215/CJN.03500412.

7.

Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study.

Nakayama M, Kaizu Y, Nagata M, Ura Y, Ikeda H, Shimamoto S, Kuma K.

BMC Nephrol. 2013 Jan 22;14:22. doi: 10.1186/1471-2369-14-22.

8.

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators..

JAMA Cardiol. 2016 Aug 1;1(5):548-56. doi: 10.1001/jamacardio.2016.1445.

PMID:
27434583
9.

Not all inflammatory markers are linked to kidney function: results from a population-based study.

Pruijm M, Ponte B, Vollenweider P, Mooser V, Paccaud F, Waeber G, Marques-Vidal P, Burnier M, Bochud M.

Am J Nephrol. 2012;35(3):288-94. doi: 10.1159/000335934.

PMID:
22398717
10.

Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.

Sarmento-Dias M, Santos-Araújo C, Poínhos R, Oliveira B, Silva IS, Silva LS, Sousa MJ, Correia F, Pestana M.

Clin Nephrol. 2016 Mar;85(3):135-41. doi: 10.5414/CN108716.

PMID:
26833300
11.

Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease.

Lin CJ, Pan CF, Chuang CK, Liu HL, Sun FJ, Wang TJ, Chen HH, Wu CJ.

Am J Med Sci. 2014 May;347(5):370-6. doi: 10.1097/MAJ.0b013e3182989f26.

PMID:
24051956
12.

Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.

van Breda F, Emans ME, van der Putten K, Braam B, van Ittersum FJ, Kraaijenhagen RJ, de Borst MH, Vervloet M, Gaillard CA.

PLoS One. 2015 Jun 16;10(6):e0128994. doi: 10.1371/journal.pone.0128994.

13.

Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Wright CB, Shah NH, Mendez AJ, DeRosa JT, Yoshita M, Elkind MS, Sacco RL, DeCarli C, Rundek T, Silverberg S, Dong C, Wolf M.

Stroke. 2016 Apr;47(4):923-8. doi: 10.1161/STROKEAHA.115.012379.

PMID:
26956260
14.

Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.

Jovanovich A, Ix JH, Gottdiener J, McFann K, Katz R, Kestenbaum B, de Boer IH, Sarnak M, Shlipak MG, Mukamal KJ, Siscovick D, Chonchol M.

Atherosclerosis. 2013 Nov;231(1):114-9. doi: 10.1016/j.atherosclerosis.2013.09.002.

15.

Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD.

Zhang LN, Yang G, Cheng C, Shen C, Cui YY, Zhang J, Zhang JJ, Shen ZX, Zeng M, Ge YF, Sun B, Yu XB, Ouyang C, Zhang B, Mao HJ, Liu J, Xing CY, Zha XM, Wang NN.

Osteoporos Int. 2015 Jan;26(1):395-405. doi: 10.1007/s00198-014-2862-7.

PMID:
25224292
16.

Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.

Shah NH, Dong C, Elkind MS, Sacco RL, Mendez AJ, Hudson BI, Silverberg S, Wolf M, Rundek T, Wright CB.

Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):2048-53. doi: 10.1161/ATVBAHA.115.305945.

17.

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.

Lundberg S, Qureshi AR, Olivecrona S, Gunnarsson I, Jacobson SH, Larsson TE.

Clin J Am Soc Nephrol. 2012 May;7(5):727-34. doi: 10.2215/CJN.10331011.

18.

Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals.

Isakova T, Cai X, Lee J, Katz R, Cauley JA, Fried LF, Hoofnagle AN, Satterfield S, Harris TB, Shlipak MG, Sarnak MJ, Ix JH; Health ABC Study..

J Bone Miner Res. 2016 Apr;31(4):742-8. doi: 10.1002/jbmr.2750.

PMID:
26590361
19.

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Okada N, Tsubakihara Y, Isaka Y, Rakugi H.

Clin J Am Soc Nephrol. 2012 May;7(5):810-9. doi: 10.2215/CJN.08680811.

20.

Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.

Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D'Arrigo G, Abd ElHafeez S, Tripepi G, Mallamaci F, Zoccali C.

Eur J Clin Invest. 2016 Mar;46(3):234-41. doi: 10.1111/eci.12588.

PMID:
26728476

Supplemental Content

Support Center